Reply: Multivessel Versus Culprit-Vessel PCI in Patients With NSTEMI and Cardiogenic Shock

Funding

Dr Omer has reported that he has no relationships relevant to the contents of this paper to disclose. Dr Brilakis has received consulting fees and/or speaker honoraria from Abbott Vascular, American Heart Association (Associate Editor, Circulation), Amgen, Biotronik, Boston Scientific, Cardiovascular Innovations Foundation (Board of Directors), ControlRad, CSI, Ebix, Elsevier, GE Healthcare, InfraRedx, Medtronic, Siemens, and Teleflex; has received research support from Regeneron and Siemens; is an owner of Hippocrates; and is a shareholder of MHI Ventures. Dr Elgendy has received research grants from Caladrius Biosciences unrelated to this manuscript content. Dr Chan is supported by a grant from the National Heart, Lung, and Blood Institute (1R01HL123980). Dr Spertus has received grant funding from the National Institutes of Health, Patient-Centered Outcomes Research Institute, Abbott Vascular, and Bayer; has an equity interest in Health Outcomes Sciences; has a copyright to the Seattle Angina Questionnaire; and has served as a consultant to Novartis, Bayer, United Healthcare, and AstraZeneca. Dr Omer has reported that he has no relationships relevant to the contents of this paper to disclose. Dr Brilakis has received consulting fees and/or speaker honoraria from Abbott Vascular, American Heart Association (Associate Editor, Circulation), Amgen, Biotronik, Boston Scientific, Cardiovascular Innovations Foundation (Board of Directors), ControlRad, CSI, Ebix, Elsevier, GE Healthcare, InfraRedx, Medtronic, Siemens, and Teleflex; has received research support from Regeneron and Siemens; is an owner of Hippocrates; and is a shareholder of MHI Ventures. Dr Elgendy has received research grants from Caladrius Biosciences unrelated to this manuscript content. Dr Chan is supported by a grant from the National Heart, Lung, and Blood Institute (1R01HL123980). Dr Spertus has received grant funding from the National Institutes of Health, Patient-Centered Outcomes Research Institute, Abbott Vascular, and Bayer; has an equity interest in Health Outcomes Sciences; has a copyright to the Seattle Angina Questionnaire; and has served as a consultant to Novartis, Bayer, United Healthcare, and AstraZeneca.